Skip to main content
SMFM 2026 Pregnancy Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Additional registration fee required
Additional registration fee required
Faculty have requested this content not be shared outside of the session
Faculty have requested this content not be shared outside of the session
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Recording available 2/16-5/2
Recording available 2/16-5/2
AIUM Credit
AIUM Credit
Foundation Awardee
Foundation Awardee
Poster Icons
Abstract Award
Abstract Award
Foundation Awardee
Foundation Awardee

Poster Session 3

Category: Healthcare Policy/Economics

Poster Session 3

(801) The frequency and severity of complications after previable PROM in Colorado following Dobbs decision

Thursday, February 12, 2026
10:30 AM - 12:00 PM  
Objective:
Previous studies have shown an increase in complications after a restrictive abortion law. In these studies, the delays in care were due to confusion around the laws preventing physicians from providing immediate intervention. We aim to compare the outcomes of pregnancies with previable PROM pre- and post-Dobbs decision in a state with protected abortion care access.

Study Design:
This is a retrospective cohort study of a tertiary care center from January 1, 2018-December 31, 2024. Pre-existing perinatal database (PARITY) was queried to identify singleton pregnancy with the diagnosis of previable PROM before 22 weeks. Baseline demographics, and clinical characteristics were abstracted by the authors. The study cohort is divided into pre- and post-Dobbs group (June 24th, 2022) and clinical characteristics and outcomes were compared. Our primary outcome was composite adverse outcome including maternal ICU admission, transfusion, or sepsis. Multivariable logistic regression was used to adjust for confounding factors.  

Results:
A total of 237 pregnancies were included in this analysis, 134 pregnancies pre-Dobbs and 103 pregnancies post-Dobbs. There were no clinically significant differences in baseline characteristics in the study groups (Table 1). There was no difference in immediate delivery rate pre- 20.9% vs 21.6% post-Dobbs (p< 0.9). There was also no difference in time from rupture to delivery pre- and post-Dobbs (median [IQR]: 1 [1-8.75] days vs 2 [1-8] days, p 0.56). There was no significant difference in incidence of sepsis (5.2% pre-Dobbs vs 3.9% post-Dobbs, p 0.62). After adjusting for age, race and ethnicity, and gestational age at delivery there was no difference in the rate of composite adverse outcomes (12.7% pre-Dobbs vs 9.7% post-Dobbs, aOR=0.69, CI 0.30, 1.63). 

Conclusion:
We did not see an increase in composite adverse outcomes pre- and post-Dobbs in a state with protected abortion care access. The increase previously seen in abortion restrictive states likely is associated to state specific legislation that leads to delays in evidence-based care.